Dr. Clint Cary’s research efforts focus on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and prostate cancer. He has a study in progress to assess utilization rates of single dose intravesical chemotherapy in patients with non-muscle invasive bladder cancer in a population-based environment.
He actively publishes on advanced testicular cancer outcomes in numerous high-impact journals and has authored numerous book chapters on the topic of testicular cancer.
He provides direct medical and surgical care, with a specific focus on patients with testicular cancer and bladder cancer.
His clinical interest is in urologic oncology with a focus on the surgical managment of advanced testicular cancer and bladder cancer. His research efforts focus on health services and outcomes research in testis and bladder cancer.
Dr. Cary's primary research interest involves testicular cancer. He has published numerous peer-reviewed publications describing the surgical management and outcomes in patients with advanced germ cell tumors. He is currently involved with several projects including a Pilot study in patients with clinical stage I testicular cancer to understand how they make treatment decisions.
Dr. Cary’s research interests predominantly focus on the surgical management of advanced testicular cancer and subsequent outcomes. He leads the urologic oncology research effort within the Department of Urology.
He has published numerous peer-reviewed journal articles on prostate, bladder, kidney, and testicular cancer. He has authors text-book chapters on the surgical management of testicular and bladder cancer.
